Amedeo Smart

Free Medical Literature Service


 

Amedeo

Malignant Lymphoma

  Free Subscription

Articles published in
Oncol Rep
    October 2023
  1. JIN C, Zhou D, Li J, Bi L, et al
    Single‑cell multi‑omics advances in lymphoma research (Review).
    Oncol Rep. 2023;50:184.
    >> Share

    July 2023
  2. CHEN Y, Tao H, Wang F, Wu P, et al
    Artesunate synergistically promotes sorafenib‑induced apoptosis and ferroptosis in non‑Hodgkin lymphoma cells through inhibition of the STAT3 pathway.
    Oncol Rep. 2023;50:147.
    >> Share

    May 2023
  3. ZENG H, Wang J, Xu B, Deng H, et al
    Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma.
    Oncol Rep. 2023;49:88.
    >> Share

  4. WANG H, Xiong M, Hu Y, Sun Y, et al
    [Retracted] MicroRNA‑19b inhibits proliferation of gastric cancer cells by targeting B‑cell CLL/lymphoma 3.
    Oncol Rep. 2023;49:104.
    >> Share

    February 2023
  5. XING X, Liu M, Wang X, Guo Q, et al
    Promoting effects of calponin 3 on the growth of diffuse large B‑cell lymphoma cells.
    Oncol Rep. 2023;49:46.
    >> Share

    January 2023
  6. CAO L, Zhang M, Zhang Y, Ji B, et al
    Progress of radiological‑pathological workflows in the differential diagnosis between primary central nervous system lymphoma and high‑grade glioma (Review).
    Oncol Rep. 2023;49:20.
    >> Share

    June 2022
  7. LALIC H, Aurer I, Batinic D, Visnjic D, et al
    Bendamustine: A review of pharmacology, clinical use and immunological effects (Review).
    Oncol Rep. 2022;47.
    >> Share

    March 2022
  8. KADOTA A, Moriguchi M, Watanabe T, Sekine Y, et al
    A pyridiniumtype fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of betacatenin.
    Oncol Rep. 2022;47.
    >> Share

    January 2022
  9. FRAZZI R, Cusenza VY, Pistoni M, Canovi L, et al
    KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells.
    Oncol Rep. 2022;47.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016